Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Ruth Olmer
  • Lena Engels
  • Abdulai Usman
  • Sandra Menke
  • Muhammad Nasir Hayat Malik
  • Frank Pessler
  • Gudrun Göhring
  • Dorothee Bornhorst
  • Svenja Bolten
  • Salim Abdelilah-Seyfried
  • Thomas Scheper
  • Henning Kempf
  • Robert Zweigerdt
  • Ulrich Martin

Organisationseinheiten

Externe Organisationen

  • Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
  • Centre for Individualised Infection Medicine (CiiM)
  • Universität Potsdam
  • Deutsches Zentrum für Lungenforschung (DZL)
  • Medizinische Hochschule Hannover (MHH)
  • TWINCORE Zentrum für Experimentelle und Klinische Infektionsforschung GmbH
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)1657-1672
Seitenumfang16
FachzeitschriftStem cell reports
Jahrgang10
Ausgabenummer5
PublikationsstatusVeröffentlicht - 19 Apr. 2018

Abstract

Endothelial cells (ECs) are involved in a variety of cellular responses. As multifunctional components of vascular structures, endothelial (progenitor) cells have been utilized in cellular therapies and are required as an important cellular component of engineered tissue constructs and in vitro disease models. Although primary ECs from different sources are readily isolated and expanded, cell quantity and quality in terms of functionality and karyotype stability is limited. ECs derived from human induced pluripotent stem cells (hiPSCs) represent an alternative and potentially superior cell source, but traditional culture approaches and 2D differentiation protocols hardly allow for production of large cell numbers. Aiming at the production of ECs, we have developed a robust approach for efficient endothelial differentiation of hiPSCs in scalable suspension culture. The established protocol results in relevant numbers of ECs for regenerative approaches and industrial applications that show in vitro proliferation capacity and a high degree of chromosomal stability. In this article, U. Martin and colleagues show the generation of hiPSC endothelial cells in scalable cultures in up to 100 mL culture volume. The generated ECs show in vitro proliferation capacity and a high degree of chromosomal stability after in vitro expansion. The established protocol allows to generate hiPSC-derived ECs in relevant numbers for regenerative approaches.

ASJC Scopus Sachgebiete

  • Biochemie, Genetik und Molekularbiologie (insg.)
  • Biochemie
  • Biochemie, Genetik und Molekularbiologie (insg.)
  • Genetik
  • Biochemie, Genetik und Molekularbiologie (insg.)
  • Entwicklungsbiologie
  • Biochemie, Genetik und Molekularbiologie (insg.)
  • Zellbiologie

Ziele für nachhaltige Entwicklung

Zitieren

Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture. / Olmer, Ruth; Engels, Lena; Usman, Abdulai et al.
in: Stem cell reports, Jahrgang 10, Nr. 5, 19.04.2018, S. 1657-1672.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Olmer, R, Engels, L, Usman, A, Menke, S, Malik, MNH, Pessler, F, Göhring, G, Bornhorst, D, Bolten, S, Abdelilah-Seyfried, S, Scheper, T, Kempf, H, Zweigerdt, R & Martin, U 2018, 'Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture', Stem cell reports, Jg. 10, Nr. 5, S. 1657-1672. https://doi.org/10.1016/j.stemcr.2018.03.017, https://doi.org/10.15488/3324
Olmer, R., Engels, L., Usman, A., Menke, S., Malik, M. N. H., Pessler, F., Göhring, G., Bornhorst, D., Bolten, S., Abdelilah-Seyfried, S., Scheper, T., Kempf, H., Zweigerdt, R., & Martin, U. (2018). Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture. Stem cell reports, 10(5), 1657-1672. https://doi.org/10.1016/j.stemcr.2018.03.017, https://doi.org/10.15488/3324
Olmer R, Engels L, Usman A, Menke S, Malik MNH, Pessler F et al. Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture. Stem cell reports. 2018 Apr 19;10(5):1657-1672. doi: 10.1016/j.stemcr.2018.03.017, 10.15488/3324
Olmer, Ruth ; Engels, Lena ; Usman, Abdulai et al. / Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture. in: Stem cell reports. 2018 ; Jahrgang 10, Nr. 5. S. 1657-1672.
Download
@article{5bccd6f34110427299f1f51c31d49970,
title = "Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture",
abstract = "Endothelial cells (ECs) are involved in a variety of cellular responses. As multifunctional components of vascular structures, endothelial (progenitor) cells have been utilized in cellular therapies and are required as an important cellular component of engineered tissue constructs and in vitro disease models. Although primary ECs from different sources are readily isolated and expanded, cell quantity and quality in terms of functionality and karyotype stability is limited. ECs derived from human induced pluripotent stem cells (hiPSCs) represent an alternative and potentially superior cell source, but traditional culture approaches and 2D differentiation protocols hardly allow for production of large cell numbers. Aiming at the production of ECs, we have developed a robust approach for efficient endothelial differentiation of hiPSCs in scalable suspension culture. The established protocol results in relevant numbers of ECs for regenerative approaches and industrial applications that show in vitro proliferation capacity and a high degree of chromosomal stability. In this article, U. Martin and colleagues show the generation of hiPSC endothelial cells in scalable cultures in up to 100 mL culture volume. The generated ECs show in vitro proliferation capacity and a high degree of chromosomal stability after in vitro expansion. The established protocol allows to generate hiPSC-derived ECs in relevant numbers for regenerative approaches.",
keywords = "endothelial cells, hiPSC differentiation, scalable culture",
author = "Ruth Olmer and Lena Engels and Abdulai Usman and Sandra Menke and Malik, {Muhammad Nasir Hayat} and Frank Pessler and Gudrun G{\"o}hring and Dorothee Bornhorst and Svenja Bolten and Salim Abdelilah-Seyfried and Thomas Scheper and Henning Kempf and Robert Zweigerdt and Ulrich Martin",
note = "Funding information: We thank Dr. A. Haase for providing hiPSCs, Dr K. Osetek for isolation of hUVEC as well as hCBECs, and M. Szepes for performing tube-forming assay of hUVECs. We thank M. L{\"o}nne and A. Franke for technical assistance. This work was funded by the German Research Foundation ( KFO311 , MA 2331/18-1 ; MA 2331/15-1 , SFB958 , SE2016/7-2 , SE2016/10-1 , ZW64/4-1 , and KFO311- ZW64/7-1 ), the German Center for Lung Research (DZL, BREATH 82DZL002A1 ), and the German Research Foundation (Cluster of Excellence REBIRTH, EXC 62), by the German Ministry for Education and Science (BMBF, grants: 13N14086 , 01EK1601A , and 01EK1602A ), by the European Union (TECHNOBEAT, grant 668724 ), and by StemBANCC (receiving support from the Innovative Medicines Initiative joint undertaking under grant 115439-2 , whose resources are composed of financial contribution from the European Union [ FP7/2007-2013 ] and EFPIA companies' in-kind contribution).",
year = "2018",
month = apr,
day = "19",
doi = "10.1016/j.stemcr.2018.03.017",
language = "English",
volume = "10",
pages = "1657--1672",
journal = "Stem cell reports",
issn = "2213-6711",
publisher = "Cell Press",
number = "5",

}

Download

TY - JOUR

T1 - Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture

AU - Olmer, Ruth

AU - Engels, Lena

AU - Usman, Abdulai

AU - Menke, Sandra

AU - Malik, Muhammad Nasir Hayat

AU - Pessler, Frank

AU - Göhring, Gudrun

AU - Bornhorst, Dorothee

AU - Bolten, Svenja

AU - Abdelilah-Seyfried, Salim

AU - Scheper, Thomas

AU - Kempf, Henning

AU - Zweigerdt, Robert

AU - Martin, Ulrich

N1 - Funding information: We thank Dr. A. Haase for providing hiPSCs, Dr K. Osetek for isolation of hUVEC as well as hCBECs, and M. Szepes for performing tube-forming assay of hUVECs. We thank M. Lönne and A. Franke for technical assistance. This work was funded by the German Research Foundation ( KFO311 , MA 2331/18-1 ; MA 2331/15-1 , SFB958 , SE2016/7-2 , SE2016/10-1 , ZW64/4-1 , and KFO311- ZW64/7-1 ), the German Center for Lung Research (DZL, BREATH 82DZL002A1 ), and the German Research Foundation (Cluster of Excellence REBIRTH, EXC 62), by the German Ministry for Education and Science (BMBF, grants: 13N14086 , 01EK1601A , and 01EK1602A ), by the European Union (TECHNOBEAT, grant 668724 ), and by StemBANCC (receiving support from the Innovative Medicines Initiative joint undertaking under grant 115439-2 , whose resources are composed of financial contribution from the European Union [ FP7/2007-2013 ] and EFPIA companies' in-kind contribution).

PY - 2018/4/19

Y1 - 2018/4/19

N2 - Endothelial cells (ECs) are involved in a variety of cellular responses. As multifunctional components of vascular structures, endothelial (progenitor) cells have been utilized in cellular therapies and are required as an important cellular component of engineered tissue constructs and in vitro disease models. Although primary ECs from different sources are readily isolated and expanded, cell quantity and quality in terms of functionality and karyotype stability is limited. ECs derived from human induced pluripotent stem cells (hiPSCs) represent an alternative and potentially superior cell source, but traditional culture approaches and 2D differentiation protocols hardly allow for production of large cell numbers. Aiming at the production of ECs, we have developed a robust approach for efficient endothelial differentiation of hiPSCs in scalable suspension culture. The established protocol results in relevant numbers of ECs for regenerative approaches and industrial applications that show in vitro proliferation capacity and a high degree of chromosomal stability. In this article, U. Martin and colleagues show the generation of hiPSC endothelial cells in scalable cultures in up to 100 mL culture volume. The generated ECs show in vitro proliferation capacity and a high degree of chromosomal stability after in vitro expansion. The established protocol allows to generate hiPSC-derived ECs in relevant numbers for regenerative approaches.

AB - Endothelial cells (ECs) are involved in a variety of cellular responses. As multifunctional components of vascular structures, endothelial (progenitor) cells have been utilized in cellular therapies and are required as an important cellular component of engineered tissue constructs and in vitro disease models. Although primary ECs from different sources are readily isolated and expanded, cell quantity and quality in terms of functionality and karyotype stability is limited. ECs derived from human induced pluripotent stem cells (hiPSCs) represent an alternative and potentially superior cell source, but traditional culture approaches and 2D differentiation protocols hardly allow for production of large cell numbers. Aiming at the production of ECs, we have developed a robust approach for efficient endothelial differentiation of hiPSCs in scalable suspension culture. The established protocol results in relevant numbers of ECs for regenerative approaches and industrial applications that show in vitro proliferation capacity and a high degree of chromosomal stability. In this article, U. Martin and colleagues show the generation of hiPSC endothelial cells in scalable cultures in up to 100 mL culture volume. The generated ECs show in vitro proliferation capacity and a high degree of chromosomal stability after in vitro expansion. The established protocol allows to generate hiPSC-derived ECs in relevant numbers for regenerative approaches.

KW - endothelial cells

KW - hiPSC differentiation

KW - scalable culture

UR - http://www.scopus.com/inward/record.url?scp=85045438454&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2018.03.017

DO - 10.1016/j.stemcr.2018.03.017

M3 - Article

C2 - 29681541

AN - SCOPUS:85045438454

VL - 10

SP - 1657

EP - 1672

JO - Stem cell reports

JF - Stem cell reports

SN - 2213-6711

IS - 5

ER -

Von denselben Autoren